Riskpilot← Back to searchSign inGet full accessFysioterapia Forte Oy
OYActiveY-tunnus 0702668-4Sillanpäänkuja 4Physiotherapy activities · NACE 8695Est. 1988— employeeswww.fysioterapiaforte.fi
Revenue 2025
EUR 266K
-11% vs 2024
EBITDA margin
18.7%
-45% vs 2024
Equity ratio
50.9%
Financial strength
Net profit 2025
EUR -16K
-163% vs 2024
| Revenue | EUR 266K | -11% |
| EBITDA | EUR 50K | -45% |
| Net profit | EUR -16K | -163% |
| Total assets | EUR 410K | -12% |
| Equity | EUR 209K | -17% |
| Employees | — | — |
Legal name
Fysioterapia Forte Oy
Y-tunnus number
0702668-4
Legal form
Osakeyhtiö
NACE code
8695 · Physiotherapy activities
Founded
31. toukokuuta 1988
Share capital
EUR 2 523
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön päätoimialana on Fysioterapia- ja hyvinvointipalveluiden antaminen ja alan tuotteiden myynti ja valmistus, sekä toiminnassa tarvittavan kiinteän ja irtaimen omaisuuden omistaminen ja hallinta. Yhtiön alatoimialana on kaikki muu laillinen liiketoiminta.
Address
Sillanpäänkuja 4
Phone
+3580451263929
Website
www.fysioterapiaforte.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 369 | 305 | 338 | 300 | 266 |
| Staff expenses | −181 | −140 | −180 | −147 | −155 |
| EBITDA | 120 | 113 | 99 | 90 | 50 |
| Depreciation & amort. | −41 | −37 | −56 | −51 | −55 |
| EBIT | 79 | 76 | 43 | 39 | −5 |
| Net financials | −5 | −5 | 1 | −8 | −11 |
| Profit before tax | 74 | 72 | 43 | 32 | −16 |
| Tax | 15 | 14 | 9 | 7 | 0 |
| Net profit | 59 | 57 | 35 | 25 | −16 |
| Item | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 455 | 522 | 571 | 464 | 410 |
| Equity | 209 | 250 | 264 | 252 | 209 |
| Long-term debt | 150 | 186 | 209 | 119 | 121 |
| Short-term debt | 95 | 86 | 98 | 92 | 80 |
| Total debt | 245 | 272 | 307 | 211 | 201 |
EBITDA margin
18.7%
This company
15.8%
Market median
+18% vs market
20202025
Equity ratio
50.9%
This company
38.2%
Market median
+33% vs market
20202025
Return on equity
-7.5%
This company
18.4%
Market median
-141% vs market
20202025
Net profit margin
-5.9%
This company
8.1%
Market median
-173% vs market
20202025
Asset turnover
0.65×
This company
1.12×
Market median
-42% vs market
20202025
Debt / equity
0.96×
This company
0.62×
Market median
+55% vs market
20202025
- Annual report 2025Filed via PRH / YTJ · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-04-01 – 2024-03-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-04-01 – 2021-03-31
- Annual report 2020Filed via PRH / YTJ · Period 2019-04-01 – 2020-03-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
MK Deputy auditor | Deputy auditor | 2018 |
VJ Chief Executive Officer | Chief Executive Officer | 2008 |
KH Deputy Member | Deputy Member | 2010 |
TM Audit | Audit | 2022 |
| Former (1) | ||
TJ | Audit | 2018 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairperson | 2010 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Fysioterapia Forte Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Turo Jouko Juhani Jaakkola | Audit | 0 companies |
| Marjo Kaija Helena Lähteenmaa | Deputy auditor | 0 companies |
| Veli-Pekka Jalmari Haapala | Chief Executive Officer | 0 companies |
| Kaisa Heleena Sahakangas | Deputy Member | 0 companies |
| Tiina Maria Ventelä | Audit | 0 companies |
| Tiina-Liisa Haapala | Chairperson | 0 companies |